|
1
|
Hansson GK: Inflammation, atherosclerosis
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bermudez EA, Rifai N, Buring J, Manson JE
and Ridker PM: Interrelationships among circulating interleukin-6,
C-reactive protein and traditional cardiovascular risk factors in
women. Arterioscler Thromb Vasc Biol. 22:1668–1673. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lind L: Circulating markers of
inflammation and atherosclerosis. Atherosclerosis. 169:203–214.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huber SA, Sakkinen P, Conze D, Hardin N
and Tracy R: Interleukin-6 exacerbates early atherosclerosis in
mice. Arterioscler Thromb Vasc Biol. 19:2364–2367. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross R: Atherosclerosisan inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lominadze D, Dean WL, Tyagi SC and Roberts
AM: Mechanisms of fibrinogen-induced microvascular dysfunction
during cardiovascular disease. Acta Physiol (Oxf). 198:1–13. 2010.
View Article : Google Scholar
|
|
8
|
Sen U, Tyagi N, Patibandla PK, Dean WL,
Tyagi SC, Roberts AM and Lominadze D: Fibrinogen-induced
endothelin-1 production from endothelial cells. Am J Physiol Cell
Physiol. 296:C840–C847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szaba FM and Smiley ST: Roles for thrombin
and fibrin(ogen) in cytokine/chemokine production and macrophage
adhesion in vivo. Blood. 99:1053–1059. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robson SC, Shephard EG and Kirsch RE:
Fibrin degradation product D-dimer induces the synthesis and
release of biologically active IL-lbeta, IL-6 and plasminogen
activator inhibitors from monocytes in vitro. Br J Haematol.
86:322–326. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuhns DB, Nelson EL, Alvord WG and Gallin
JI: Fibrinogen induces IL-8 synthesis in human neutrophils
stimulated with formyl-methionyl-leucyl-phenylalanine or
leukotriene B(4). J Immunol. 167:2869–2878. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsakadze NL, Zhao Z and D'Souza SE:
Interaction of inter-cellular adhesion molecule-1 with fibrinogen.
Trends Cardiovasc Med. 12:101–108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mosesson MW: Fibrinogen and fibrin
structure and functions. J Thromb Haemost. 3:1894–1904. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tyagi N, Roberts AM, Dean WL, Tyagi SC and
Lominadze D: Fibrinogen induces endothelial cell permeability. Mol
Cell Biochem. 307:13–22. 2008. View Article : Google Scholar
|
|
15
|
Patibandla PK, Tyagi N, Dean WL, Tyagi SC,
Roberts AM and Lominadze D: Fibrinogen induces alterations of
endothelial cell tight junction proteins. J Cell Physiol.
221:195–203. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rauch BH, Müschenborn B, Braun M, Weber AA
and Schrör K: ICAM-1 and p38 MAPK mediate fibrinogen-induced
migration of human vascular smooth muscle cells. Eur J Pharmacol.
577:54–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naito M, Stirk CM, Smith EB and Thompson
WD: Smooth muscle cell outgrowth stimulated by fibrin degradation
products: The potential role of fibrin fragment E in restenosis and
atherogenesis. Thromb Res. 98:165–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hicks RC, Golledge J, Mir-Hasseine R and
Powell JT: Vasoactive effects of fibrinogen on saphenous vein.
Nature. 379:818–820. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo F, Liu JT, Wang CJ, Liu N and Lu PP:
Fibrinogen, fibrin and FDP induce C-reactive protein generation in
rat vascular smooth muscle cells: Pro-inflammatory effect on
atherosclerosis. Biochem Biophy Res Commun. 390:942–946. 2009.
View Article : Google Scholar
|
|
20
|
Lu PP, Liu JT, Liu N, Guo F, Ji YY and
Pang X: Pro-inflammatory effect of fibrinogen and FDP on vascular
smooth muscle cells by IL-6, TNF-α and iNOS. Life Sci. 88:839–845.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Veillard NR and Mach F: Statins: The new
aspirin? Cell Mol Life Sci. 59:1771–1786. 2002. View Article : Google Scholar
|
|
22
|
Gaugler MH, Vereycken-Holler V, Squiban C,
Vandamme M, Vozenin-Brotons MC and Benderitter M: Pravastatin
limits endothelial activation after irradiation and decreases the
resulting inflammatory and thrombotic responses. Radiat Res.
163:479–487. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hadrava V, Tremblay J and Hamet P:
Abnormalities in growth characteristics of aortic smooth muscle
cells in spontaneously hypertensive rats. Hypertension. 13:589–597.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takemoto M and Liao JK: Pleiotropic
effects of 3-hydroxy-3-meth-ylglutaryl coenzyme a reductase
inhibitors. Arterioscler Thromb Vasc Biol. 21:1712–1719. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tedgui A and Mallat Z: Cytokines in
atherosclewrosis: Pathogenic and regulatory pathways. Physiol Rev.
86:515–581. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kosmala W, Przewlocka-Kosmala M and
Mazurek W: Proinflammatory cytokines and myocardial viability in
patients after acute myocardial infarction. Int J Cardiol.
101:449–456. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Buttery LD, Springall DR, Chester AH,
Evans TJ, Standfield EN, Parums DV, Yacoub MH and Polak JM:
Inducible nitric oxide synthase is present within human
atherosclerotic lesions and promotes the formation and activity of
peroxynitrite. Lab Invest. 75:77–85. 1996.PubMed/NCBI
|
|
29
|
Luoma JS, Strålin P, Marklund SL, Hiltunen
TP, Särkioja T and Ylä-Herttuala S: Expression of extracellular SOD
and iNOS in macrophages and smooth muscle cells in human and rabbit
atherosclerotic lesions: Colocalization with epitopes
characteristic of oxidized LDL and peroxynitrite-modified proteins.
Arterioscler Thromb Vasc Biol. 18:157–167. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Radomski MW and Salas E: Nitric
oxide-biological mediator, modulator and factor of injury: its role
in the pathogenesis of atherosclerosis. Atherosclerosis.
118(Suppl): S69–S80. 1995. View Article : Google Scholar
|
|
31
|
Smith EB, Thompson WD, Crosbie L and Stirk
CM: Fibrinogen/fibrin in atherogenesis. Eur J Epidemiol. 8(Suppl
1): 83–87. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perez RL and Roman J: Fibrin enhances the
expression of IL-lbeta by human peripheral blood mononuclear cells.
Implications in pulmonary inflammation. J Immunol. 154:1879–1887.
1995.PubMed/NCBI
|
|
33
|
Lin R, Liu J, Peng N, Yang G, Gan W and
Wang W: Lovastatin reduces nuclear factor kappaB activation induced
by C-reactive protein in human vascular endothelial cells. Biol
Pharm Bull. 28:1630–1634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng N, Liu JT, Gao DF, Lin R and Li R:
Angiotensin II-induced C-reactive protein generation: Inflammatory
role of vascular smooth muscle cells in atherosclerosis.
Atherosclerosis. 193:292–298. 2007. View Article : Google Scholar
|
|
35
|
Wang C, Liu J, Guo F, Ji Y and Liu N:
Endothelin-1 induces the expression of C-reactive protein in rat
vascular smooth muscle cells. Biochem Biophys Res Commun.
389:537–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han C, Liu J, Liu X and Li M: Angiotensin
II induces C-reactive protein expression through ERK1/2 and JNK
signaling in human aortic endothelial cells. Atherosclerosis.
212:206–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li M, Liu J, Han C, Wang B, Pang X and Mao
J: Angiotensin II induces the expression of c-reactive protein via
MAPK-dependent signal pathway in U937 macrophages. Cell Physiol
Biochem. 27:63–70. 2011.PubMed/NCBI
|
